BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34748059)

  • 1. The impact of drainage pathways on the detection of nodal metastases in prostate cancer: a phase II randomized comparison of intratumoral vs intraprostatic tracer injection for sentinel node detection.
    Wit EMK; van Beurden F; Kleinjan GH; Grivas N; de Korne CM; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1743-1753. PubMed ID: 34748059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
    Wit EMK; KleinJan GH; Berrens AC; van Vliet R; van Leeuwen PJ; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2861-2871. PubMed ID: 37036490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical localization of radiocolloid tracer deposition affects outcome of sentinel node procedures in prostate cancer.
    de Korne CM; Wit EM; de Jong J; Valdés Olmos RA; Buckle T; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2558-2568. PubMed ID: 31377820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients.
    Buckle T; Brouwer OR; Valdés Olmos RA; van der Poel HG; van Leeuwen FW
    J Nucl Med; 2012 Jul; 53(7):1026-33. PubMed ID: 22645296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer.
    KleinJan GH; van den Berg NS; Brouwer OR; de Jong J; Acar C; Wit EM; Vegt E; van der Noort V; Valdés Olmos RA; van Leeuwen FW; van der Poel HG
    Eur Urol; 2014 Dec; 66(6):991-8. PubMed ID: 25092539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery.
    KleinJan GH; van den Berg NS; de Jong J; Wit EM; Thygessen H; Vegt E; van der Poel HG; van Leeuwen FW
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1278-87. PubMed ID: 26768422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging.
    Warncke SH; Mattei A; Fuechsel FG; Z'Brun S; Krause T; Studer UE
    Eur Urol; 2007 Jul; 52(1):126-32. PubMed ID: 17258385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multispectral Fluorescence Imaging During Robot-assisted Laparoscopic Sentinel Node Biopsy: A First Step Towards a Fluorescence-based Anatomic Roadmap.
    van den Berg NS; Buckle T; KleinJan GH; van der Poel HG; van Leeuwen FWB
    Eur Urol; 2017 Jul; 72(1):110-117. PubMed ID: 27345689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles.
    Winter A; Kowald T; Paulo TS; Goos P; Engels S; Gerullis H; Schiffmann J; Chavan A; Wawroschek F
    Int J Nanomedicine; 2018; 13():6689-6698. PubMed ID: 30425483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Intraoperative Fluorescence Imaging Identify All Lesions While the Road Map Created by Preoperative Nuclear Imaging Is Masked?
    Meershoek P; Buckle T; van Oosterom MN; KleinJan GH; van der Poel HG; van Leeuwen FWB
    J Nucl Med; 2020 Jun; 61(6):834-841. PubMed ID: 31712325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.
    van der Poel HG; Buckle T; Brouwer OR; Valdés Olmos RA; van Leeuwen FW
    Eur Urol; 2011 Oct; 60(4):826-33. PubMed ID: 21458154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Hybrid Tracer Indocyanine Green- 99m Tc-Nanocolloid for Sentinel Node Biopsy in Bladder Cancer-A Prospective Pilot Study.
    Rietbergen DDD; van Gennep EJ; KleinJan GH; Donswijk M; Valdés Olmos RA; van Rhijn BW; van der Poel HG; van Leeuwen FWB
    Clin Nucl Med; 2022 Sep; 47(9):774-780. PubMed ID: 35713891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Radio-Guided Sentinel Node Detection in Patients with Prostate Cancer Undergoing Radical Prostatectomy with Modified-Extended Lymphadenectomy.
    Małkiewicz B; Bugla B; Czarnecki M; Karwacki J; Długosz P; Gurwin A; Kiełb P; Lemiński A; Krajewski W; Jędrzejuk D; Bolanowski M; Hałoń A; Szydełko T
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291796
    [No Abstract]   [Full Text] [Related]  

  • 14. Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid.
    van den Berg NS; Brouwer OR; Klop WM; Karakullukcu B; Zuur CL; Tan IB; Balm AJ; van den Brekel MW; Valdés Olmos RA; van Leeuwen FW
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1128-36. PubMed ID: 22526966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.
    Brouwer OR; Buckle T; Vermeeren L; Klop WM; Balm AJ; van der Poel HG; van Rhijn BW; Horenblas S; Nieweg OE; van Leeuwen FW; Valdés Olmos RA
    J Nucl Med; 2012 Jul; 53(7):1034-40. PubMed ID: 22645297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of radioisotope-guided sentinel lymph node biopsy in penile cancer: verification in consideration of the European guidelines.
    Schubert T; Uphoff J; Henke RP; Wawroschek F; Winter A
    BMC Urol; 2015 Sep; 15():98. PubMed ID: 26416391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer.
    Staník M; Čapák I; Macík D; Vašina J; Lžičařová E; Jarkovský J; Šustr M; Miklánek D; Doležel J
    Int Urol Nephrol; 2014 Aug; 46(8):1543-9. PubMed ID: 24682846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Specific Mapping Study Using Fluorescence Sentinel Lymph Node Detection in Patients with Intermediate- and High-risk Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection.
    Nguyen DP; Huber PM; Metzger TA; Genitsch V; Schudel HH; Thalmann GN
    Eur Urol; 2016 Nov; 70(5):734-737. PubMed ID: 26856960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.